Patient influencers are shaping conversations about treatments, disease awareness, and quality of life. But the rise of patient voices creates debate: Are they trusted advocates, or an extension of pharma’s paid campaigns? This session features an executive-level debate between industry leaders, challenging attendees to weigh the value, risks, and future of patient influence in pharma.

• Evaluating impact by scale and authenticity and understanding when to leverage macro reach vs. micro/patient authenticity
• Building influencer strategies that are transparent, ethical, and regulator-ready to balance influence with compliance
• Exploring hybrid approaches that combine patient voices with traditional campaigns to build trust and reach